The global interventional oncology market should reach $3.1 billion by 2026 from $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.
The embolization devices segment of the global interventional oncology market is expected to grow from $1.3 billion in 2021 to $1.9 billion in 2026 at a CAGR of 7.7% for the forecast period of 2021 to 2026.
The ablation devices segment of the global interventional oncology devices market is expected to grow from $1.8 billion in 2021 to $2.3 billion in 2026 at a CAGR of 4.5% for the forecast period of 2021 to 2026.
Report Scope
The current report highlights the current and future market potential of IO along with a detailed analysis of the competitive environment, regulatory scenario, technology, and the drivers, restraints, opportunities and trends affecting the market. The report also offers market projections to 2026 and market rankings for key players. The report discusses the IO market by type of products, end-user and application.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America consists of the U.S., Canada, and Mexico. Europe consists of Germany, the U.K., France, and the Rest of Europe. Asia-Pacific consists of China, India, Japan and the Rest of Asia-Pacific. For market estimates, data has been provided for 2019 as the base year, 2020 and forecasts for 2026.
The Report Includes
- 55 data tables and 12 additional tables
- A brief overview of the global market for interventional oncology (IO) as a technology-driven specialty towards cancer intervention
- Analyses of the global market trends, with historic data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global interventional oncology market size, and corresponding market share analysis by product, application, end-user and geographic region
- Highlights the current market potential of interventional oncology future directions of the market
- Detailed review of the competitive environment, regulatory scenario, technological advancement, and drivers, restraints, opportunity and trends in market growth
- Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, China, Japan and India
- Competitive landscape of the major players operating within global interventional oncology market, and their global rankings and company share analysis
- Profile descriptions of the leading vendor companies, including Becton, Dickinson and Co. (BD), Boston Scientific Corp., HealthTronics Inc. and Terumo Corp.
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Custom Research
- Related Reports
Chapter 2 Summary and Highlights
- The market for Interventional Oncology
Chapter 3 Medical Device Regulations
- Medical Device Definition and Classification
- Regulations
- U.S.
- Europe
- Interventional Oncology Devices
Chapter 4 Interventional Oncology: Market Dynamics
- Market Dynamics
- Drivers
- Restraints
- Opportunity
Chapter 5 Impact of COVID-19 Pandemic
- Outbreak
- Symptoms of COVID-19
- Progression of COVID-19
- Incubation Period
- Epidemiology
- Collaboration Between Organizations and Governments
- Spread of Disease
- Current Status and Impact on Medtech
- Elective and Noncritical Procedures
- Shift in Manufacturing
- Regulatory Delays, Clinical Trials, and Product Launches
- Supply Chain Disruptions
- Medical Tourism
- Interventional Oncology
Chapter 6 Market Breakdown by Type of Cancer
- Introduction
- Market Size and Forecast
- Market Analysis
- Liver Cancer
- Market Size and Forecast
- Market Analysis
- Lung Cancer
- Market Size and Forecast
- Market Analysis
- Breast Cancer
- Market Size and Forecast
- Market Analysis
- Kidney Cancer
- Market Size and Forecast
- Market Analysis
- Prostate Cancer
- Market Size and Forecast
- Market Analysis
- Bone Metastasis
- Market Size and Forecast
- Market Analysis
Chapter 7 Market Breakdown by Product Type
- Embolization Devices
- Market Size and Forecast
- Market Analysis
- Ablation Devices
- Market Size and Forecast
- Market Analysis
Chapter 8 Market Breakdown by End User
- Hospitals
- Market Size and Forecast
- Market Analysis
- Ambulatory Surgical Centers
- Market Size and Forecast
- Market Analysis
Chapter 9 Market Breakdown by Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Rest of the World
Chapter 10 Competitive Landscape
- Global Company Market Share Analysis
Chapter 11 Company Profiles
- Becton, Dickinson and Co.
- Boston Scientific Corp.
- Cook Medical Inc.
- Healthtronics Inc.
- Johnson & Johnson
- Medtronic Plc
- Terumo Corp.
Chapter 12 Appendix: Abbreviations
List of Tables
Summary Table A: Global Market for Interventional Oncology, by Product Type, Through 2026
Summary Table B: Global Market for Interventional Oncology, by Type of Cancer, Through 2026
Summary Table C: Global Market for Interventional Oncology, by End User, Through 2026
Table 1: Class I and Class II Exempt Devices
Table 2: Interventional Oncology Devices
Table 3: Distribution of COVID-19 Clinical Symptoms
Table 4: Total Number of COVID-19 Confirmed Cases and Deaths Worldwide, by Country, October 28, 2021
Table 5: Global Market for Interventional Oncology, by Type of Cancer, Through 2026
Table 6: Global Market for IO Used for Liver Cancer, by Region, Through 2026
Table 7: North American Market for IO Used for Liver Cancer, by Country, Through 2026
Table 8: European Market for IO Used for Liver Cancer, by Country, Through 2026
Table 9: Asia-Pacific Market for IO Used for Liver Cancer, by Country, Through 2026
Table 10: Incidence of Liver Cancer and Associated Deaths, Worldwide, 2020
Table 11: Global Market for IO Used for Lung Cancer, by Region, Through 2026
Table 12: North American Market for IO Used for Lung Cancer, by Country, Through 2026
Table 13: European Market for IO Used for Lung Cancer, by Country, Through 2026
Table 14: Asia-Pacific Market for IO Used for Lung Cancer, by Country, Through 2026
Table 15: Incidence of Lung Cancer and Associated Deaths, Worldwide, 2020
Table 16: Global Market for IO Used for Breast Cancer, by Region, Through 2026
Table 17: North American Market for IO Used for Breast Cancer, by Country, Through 2026
Table 18: European Market for IO Used for Breast Cancer, by Country, Through 2026
Table 19: Asia-Pacific Market for IO Used for Breast Cancer, by Country, Through 2026
Table 20: Incidence of Breast Cancer and Associated Deaths, Worldwide, 2020
Table 21: Global Market for IO Used for Kidney Cancer, by Region, Through 2026
Table 22: North American Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 23: European Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 24: Asia-Pacific Market for IO Used for Kidney Cancer, by Country, Through 2026
Table 25: Global Market for Prostate Cancer, by Region, Through 2026
Table 26: North American Market for Prostate Cancer, by Country, Through 2026
Table 27: European Market for Prostate Cancer, by Country, Through 2026
Table 28: Asia-Pacific Market for Prostate Cancer, by Country, Through 2026
Table 29: Global Market for Bone Metastasis, by Region, Through 2026
Table 30: North American Market for Bone Metastasis, by Country, Through 2026
Table 31: European Market for Bone Metastasis, by Country, Through 2026
Table 32: Asia-Pacific Market for Bone Metastasis, by Country, Through 2026
Table 33: Global Market for Interventional Oncology, by Product Type, Through 2026
Table 34: Global Market for Embolization Devices, by Region, Through 2026
Table 35: North American Market for Embolization Devices, by Country, Through 2026
Table 36: European Market for Embolization Devices, by Country, Through 2026
Table 37: Asia-Pacific Market for Embolization Devices, by Country, Through 2026
Table 38: Global Market for Ablation Devices, by Region, Through 2026
Table 39: North American Market for Ablation Devices, by Country, Through 2026
Table 40: European Market for Ablation Devices, by Country, Through 2026
Table 41: Asia-Pacific Market for Ablation Devices, by Country, Through 2026
Table 42: Global Market for Interventional Oncology, by End User, Through 2026
Table 43: Global Market for Interventional Oncology Used in Hospitals, by Region, Through 2026
Table 44: North American Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 45: European Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 46: Asia-Pacific Market for Interventional Oncology Used in Hospitals, by Country, Through 2026
Table 47: Global Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Region, Through 2026
Table 48: North American Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 49: European Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 50: Asia-Pacific Market for Interventional Oncology Used in Ambulatory Surgical Centers, by Country, Through 2026
Table 51: Global Market for Interventional Oncology, by Region, Through 2026
Table 52: North American Market for Interventional Oncology, by Country, Through 2026
Table 53: European Market for Interventional Oncology, by Country, Through 2026
Table 54: Asia-Pacific Market for Interventional Oncology, by Country, Through 2026
Table 55: Global Market Share of Interventional Oncology, by Manufacturer, 2020
Table 56: BD: Business Segment
Table 57: BD: Interventional Oncology Product
Table 58: Boston Scientific: Interventional Oncology Product Portfolio
Table 59: Cook Medical: Interventional Oncology Product Portfolio
Table 60: HealthTronics: Interventional Oncology Product Portfolio
Table 61: Johnson & Johnson: Interventional Oncology Product Portfolio
Table 62: Medtronic: Interventional Oncology Product Portfolio
Table 63: Terumo: Interventional Oncology Product Portfolio
Table 64: Abbreviations and Acronyms Used in Interventional Oncology
List of Figures
Summary Figure A: Global Market for Interventional Oncology, by Product Type, 2019-2026
Summary Figure B: Global Market for Interventional Oncology, by Type of Cancer, 2019-2026
Summary Figure C: Global Market for Interventional Oncology, by End User, 2019-2026
Figure 1: Process for Marketing a Medical Device in the U.S.
Figure 2: Global Market Share of Interventional Oncology, by Type of Cancer, 2020
Figure 3: Global Market for IO Used for Liver Cancer, 2019-2026
Figure 4: Global Market for IO Used for Lung Cancer, 2019-2026
Figure 5: Global Market for IO Used for Breast Cancer, 2019-2026
Figure 6: Global Market for IO Used for Kidney Cancer, 2019-2026
Figure 7: Global Market for Prostate Cancer, 2019-2026
Figure 8: Global Market for Bone Metastasis, 2019-2026
Figure 9: Global Market Share of Interventional Oncology, by Product Type, 2020
Figure 10: Global Market for Embolization Devices, 2019-2026
Figure 11: Global Market for Ablation Devices, 2019-2026
Figure 12: Global Market Share of Interventional Oncology, by End User, 2020
Figure 13: Global Market for Interventional Oncology Used in Hospitals, 2019-2026
Figure 14: Global Market for Interventional Oncology Used in Ambulatory Surgical Centers, 2019-2026
Figure 15: Global Market Share of Interventional Oncology, by Region, 2020
Figure 16: North American Market Share of Interventional Oncology, by Country, 2020
Figure 17: U.S. Market for Interventional Oncology, 2019-2026
Figure 18: Canadian Market for Interventional Oncology, 2019-2026
Figure 19: Mexican Market for Interventional Oncology, 2019-2026
Figure 20: European Market Share of Interventional Oncology, by Country, 2020
Figure 21: German Market for Interventional Oncology, 2019-2026
Figure 22: Occupational-Related Lung Diseases Share Contributing to Annual Current Deaths in the U.K., 2019
Figure 23: U.K. Market for Interventional Oncology, 2019-2026
Figure 24: French Market for Interventional Oncology, 2019-2026
Figure 25: Rest of European Market for Interventional Oncology, 2019-2026
Figure 26: Asia-Pacific Market Share of Interventional Oncology, by Country, 2020
Figure 27: Japanese Market for Interventional Oncology, 2019-2026
Figure 28: Chinese Market for Interventional Oncology, 2019-2026
Figure 29: Indian Market for Interventional Oncology, 2019-2026
Figure 30: Rest of Asia-Pacific Market for Interventional Oncology, 2019-2026
Figure 31: RoW Market for Interventional Oncology, 2019-2026
Figure 32: BD: Annual Revenue, 2018-202
Figure 33: BD: Revenue Share, by Business Unit, 2020
Figure 34: BD: Revenue Share, by Region, 2020
Figure 35: Boston Scientific: Annual Revenue, 2018-2020
Figure 36: Boston Scientific: Revenue Share, by Product Category, 2020
Figure 37: Johnson & Johnson: Annual Revenue, 2018 and 2019
Figure 38: Johnson & Johnson: Revenue Share, by Product Category, 2020
Figure 39: Johnson & Johnson: Revenue Share, by Region, 2020
Figure 40: Medtronic: Annual Revenue, 2018-2020
Figure 41: Medtronic: Revenue Share, by Product Category, 2020
Figure 42: Terumo: Annual Revenue, 2018 and 2019
Figure 43: Terumo: Revenue Share, by Product Category, 2019
Samples
LOADING...
Executive Summary
IO is an emerging subspecialty of interventional radiography that “uses image-guided procedures to enhance cancer care,” according to a recent paper published in The Oncologist. IO has evolved over the past decade as imaging capabilities have improved and new procedures have been developed. And now, with the most advanced imaging, it is possible to use minimally invasive techniques to treat tumors. Its role in cancer treatment has been steadily growing in importance; as that same study says, “interventional oncology can now be considered the fourth pillar of modern oncology care” (the other three being medical, surgical, and radiation).
Progress in IO has been made possible by advances in cross-sectional imaging modalities: ultrasound, magnetic resonance (MR), computed tomography (CT), and positron emission tomography (PET). As interventional radiology has made technical advances, IO has leveraged them to allow physicians to provide precision cancer treatment. IO has also developed in recent years as medical oncology shifts toward more patient-centered and individualized treatment approaches. It leverages imaging to precisely plan treatment, guide the procedure, target the tumor, and assess treatment outcomes. IO is focused on three main areas of cancer intervention: diagnosis, therapy, and symptom palliation. In all cases, one major benefit is a localized effect on the tumor or a single organ in the body with minimal systemic side effects.
In this report, the global market is segmented by product type, application, end-user and region.
Companies Mentioned
- Becton, Dickinson and Co.
- Boston Scientific Corp.
- Cook Medical Inc.
- Healthtronics Inc.
- Johnson & Johnson
- Medtronic Plc
- Terumo Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 108 |
| Published | December 2021 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value ( USD | $ 2.2 Billion |
| Forecasted Market Value ( USD | $ 3.1 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 7 |
